U.S. Medical Equipment Stock News

Event overview and recent performance Monte Rosa Therapeutics (GLUE) has drawn fresh attention after recent trading. The stock closed at US$15.63 and recorded a 14.5% decline over the past month, alongside a small gain over the past 3 months. See our latest analysis for Monte Rosa Therapeutics. For context, the recent 14.5% one-month share price decline comes after a far stronger longer run. The 1-year total shareholder return is 169.5% and the 3-year total shareholder return is 131.9%. This...

Red Cat Holdings, Inc. has reported fourth-quarter 2025 sales of US$26.24 million, sharply higher than the prior year, while reducing its quarterly net loss to US$19.66 million and narrowing loss per share from US$0.33 to US$0.17. Alongside this record quarter, the company is rapidly scaling its Black Widow drone and maritime Blue Ops divisions, supported by new international defense interest including a request from Ukrainian forces to replace Chinese-made ISR drones and fresh orders from...

If you have been watching Taiwan Semiconductor Manufacturing and wondering whether the current share price still makes sense, this breakdown is designed to help you focus on what the numbers are actually saying about value. The stock recently closed at US$329.24, with returns of 3.0% year to date, 88.1% over 1 year, 267.3% over 3 years and 201.4% over 5 years. However, the share price has seen a 2.7% decline over the last 7 days and a 9.1% decline over the last 30 days. Recent attention on...

Ecolab (NYSE:ECL) agreed to acquire CoolIT Systems, a provider of liquid cooling technology for data centers, in a US$4.75b deal. The transaction expands Ecolab’s reach beyond its core water and hygiene services into data center cooling for AI infrastructure. The acquisition positions Ecolab to address demand for efficient thermal management solutions in next generation data centers. Ecolab is known for its water treatment, hygiene, and cleaning solutions across industries such as food,...

Eaton (NYSE:ETN) has launched Brightlayer Energy, an AI powered energy management platform for commercial and institutional buildings. The system is designed to optimize energy use across facilities and help monetize distributed energy resources such as on site generation and storage. Brightlayer Energy extends Eaton's AI capabilities beyond data centers into broader building energy management and grid connected assets. Eaton, trading at $356.8 per share, has seen a 22.3% return over the...

Earlier this week, MACOM Technology Solutions announced new 448G PAM4 modulator drivers supporting 400G-per-lane transmission for 1.6T and 3.2T optical transceivers, alongside showcasing high-speed interconnect solutions at OFC 2026. The company also joined Broadcom, Cisco, NVIDIA and Semtech in the new 400G Optical MSA, underscoring its role in shaping interoperable high-speed optical standards for AI and HPC data centers. Next, we’ll examine how MACOM’s 448G PAM4 drivers and 400G Optical...

Earlier this month, Okta, Inc. unveiled “Okta for AI Agents,” a platform and blueprint to discover, register, and govern AI agents, including previously unknown “shadow” agents, treating them as first-class, non-human identities with centralized access control, credential management, and an instant enterprise-wide kill switch. This move highlights how identity vendors are starting to position themselves as the control plane for rapidly growing autonomous AI usage, addressing emerging...

Clear Secure (YOU) is expanding further into healthcare, with Ochsner Health rolling out the CLEAR1 identity platform across patient and employee workflows, while investors also watch an upcoming transition in the company’s general counsel role. See our latest analysis for Clear Secure. That healthcare push and the upcoming general counsel change sit against a share price of US$48.12, with a 30-day share price return of 44.33% and a 1-year total shareholder return of 91.04%. This suggests...

Key context for Riot Platforms after recent price moves Riot Platforms (RIOT) has seen its share price move recently, with a 5.4% decline over the past day and softer performance over the past week, month, and past 3 months, drawing attention to its fundamentals. See our latest analysis for Riot Platforms. While the recent 13.6% 30 day share price decline and softer year to date share price return suggest fading short term momentum, the 68.3% 1 year total shareholder return points to a very...

Wondering whether Paylocity Holding at around US$112 per share still reflects its true worth, or if the market is mispricing it right now. The stock has inched up about 2.9% over the last week and month, yet it is still down 22.8% year to date and 41.4% over the past year, which can change how you think about its risk and potential. These moves sit against a backdrop of ongoing interest in software and HR technology companies. Investors continue to reassess what they are willing to pay for...

Humacyte, Inc. recently secured a binding minimum purchase commitment of US$1.475 million for its Symvess acellular tissue engineered vessel in Saudi Arabia, alongside filing a US$20 million follow-on common stock offering and submitting a Marketing Authorization Application for Symvess in Israel for arterial trauma repair. Taken together, these moves highlight Humacyte’s effort to turn its trauma-focused technology into an internationally adopted product, pairing early commercial traction...

Earnings event puts Teekay (TK) under the microscope Teekay (TK) just released full year 2025 results, with sales of US$949.52 million and net income of US$98.11 million, both below the prior year. This has put the stock back in focus for investors. See our latest analysis for Teekay. Teekay’s latest earnings release, which showed lower sales and net income than the prior year, comes after a strong run, with a 90 day share price return of 25.41% and a 1 year total shareholder return of...

Why Zevra Therapeutics Is On Investor Radar Today Zevra Therapeutics (ZVRA) has drawn investor attention after recent trading, with the share price closing at US$9.23 and posting mixed short term returns alongside stronger total returns over the past 3 years. See our latest analysis for Zevra Therapeutics. The recent 7 day share price return of 7.51% and 1 day decline of 1.81% come after a period of steadier momentum. The 30 day share price return of 3.82% and the 3 year total shareholder...

If you are wondering whether Eli Lilly's share price still makes sense after a strong multi year run, the key question now is how its current market price lines up with its underlying value. The stock closed at US$906.70, with returns of 9.1% over 1 year, very large gains over 3 years, and 414.3% over 5 years, while also seeing shorter term pullbacks of 8.0% over 7 days, 11.2% over 30 days, and 16.1% year to date. Recent headlines around Eli Lilly have focused heavily on its role in high...

If you are wondering whether lululemon athletica is starting to look like value or just a value trap, the current share price puts that question front and center. The stock last closed at US$162.82, with a 3.2% gain over 7 days, but declines of 10.6% over 30 days, 22.8% year to date and 49.5% over the past year highlight how sharply sentiment has shifted. These moves have come as the brand continues to sit at the crossroads of premium apparel and athleisure, where investors are weighing long...

On 10 March 2026, Corpay, Inc. announced that its Cross-Border business partnered with Formula E, becoming the exclusive Official Foreign Exchange Provider to support the all-electric ABB FIA Formula E World Championship’s multi-currency race operations across major global cities. This alliance gives Corpay a high-profile showcase for its cross-border FX and payments capabilities in a complex, fast-moving international sporting ecosystem. Next, we’ll examine how serving Formula E’s complex...

Fourth quarter and full year earnings snapshot Weis Markets (WMK) reported fourth quarter and full year 2025 results, with sales and revenue above the prior year while net income and earnings per share moved in the opposite direction, giving investors mixed signals to weigh. See our latest analysis for Weis Markets. The earnings update comes after a weaker 30 day share price return of 8.93% and a 1 year total shareholder return decline of 11.50%, suggesting momentum has softened as investors...

If you are wondering whether Constellation Energy's share price still reflects its underlying worth, you are not alone, especially after a strong multi year run that now looks more mixed in the short term. The stock recently closed at US$281.99, with returns of 27.4% over 1 year and a very large gain over 3 years, even though the share price shows a 6.6% decline over 7 days, a 4.1% decline over 30 days and a 23.0% decline year to date. Recent headlines around Constellation Energy have...

In March 2026, Wells Fargo & Company completed and announced multiple fixed-rate, callable senior and subordinated notes and a US$2.25 billion preferred depositary share issuance under its medium-term note program, spanning maturities from 2029 to 2046 across US dollar and yen markets. These offerings, coming as the Federal Reserve kept interest rates unchanged while flagging inflation and geopolitical risks, highlight Wells Fargo’s ongoing use of long-dated funding and capital instruments...

If you are wondering whether Coinbase Global's share price matches what you are actually getting for your money, this article walks through the key valuation angles that investors tend to focus on. With the stock recently closing at US$197.50 and returns of 1.0% over 7 days, 20.4% over 30 days, a 16.5% decline year to date, and 4.0% over 1 year, many investors are reassessing what counts as a reasonable price for this level of volatility. Recent headlines around Coinbase Global have focused...

In recent reports from Redfin, the real estate brokerage powered by Rocket, survey and market data highlighted AI-related job concerns, shifting housing demand, and changing affordability dynamics, alongside commentary on adjustable-rate mortgages and evolving buyer–seller balance in the U.S. housing market. Together, these findings underline how Rocket’s integrated platform, with Redfin-branded insights and mortgage options like ARMs, aims to make homeownership more accessible even as many...

Lightwave Logic, Inc. reported past full-year 2025 results, with sales of US$236,855 versus US$95,605 a year earlier and a narrower net loss of US$20.31 million versus US$22.54 million. Loss per share improved to US$0.16 from US$0.19, highlighting incremental operating progress even as the company remains firmly loss-making. We will now examine how Lightwave Logic’s higher sales alongside a reduced net loss shape the company’s evolving investment narrative. AI is about to change healthcare...

Affirm Holdings (NasdaqGS:AFRM) is facing investor questions about its liquidity profile and exposure to private-credit channels tied to LENDX. Recent sector-wide jitters in fintech funding have sharpened focus on how Affirm finances its loan book and manages counterparty risk. Analysts indicate that Affirm's funding demand and loan performance remain intact, but market sentiment has turned cautious as shareholders seek more clarity. Affirm operates in the buy now, pay later and consumer...

With Omnicom Group shares around US$75, many investors are asking whether the current price reflects the underlying value or if the stock is starting to look interesting again. Over the last month the share price has moved up 7.0%, although returns over the past year, at a 3.9% decline, have been weaker. Recent coverage has focused on how traditional advertising groups are adapting to structural changes in media buying and the rise of digital platforms. This has put more attention on how...